Related Experiment Video
Updated: Jul 17, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Hyperhomocysteinaemia: a critical review of old and new aspects
Wolfgang Herrmann1, Markus Herrmann, Rima Obeid
1Clinical Chemistry and Laboratory Medicine/Central Laboratory, Saarland University Medical School, 66421 Homburg, Germany. kchwher@uniklinikum-saarland.de
Insights
High homocysteine (HHCY) is linked to cardiovascular disease, stroke, and cognitive decline. B-vitamin supplementation effectively reduces stroke risk by approximately 20% and may lower fracture and pregnancy complication risks.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Neurology
Background:
- Hyperhomocysteinemia (HHCY), often due to B-vitamin deficiency, is a significant risk factor for cardiovascular diseases (CVD), neurodegenerative disorders, osteoporotic fractures, and pregnancy complications.
- While some vitamin intervention trials have yielded inconclusive results for CVD risk reduction, confounding factors and limited statistical power have been noted.
Purpose of the Study:
- To evaluate the effectiveness of B-vitamin supplementation in mitigating risks associated with Hyperhomocysteinemia.
- To clarify the role of B-vitamins in preventing stroke, fractures, cognitive decline, and pregnancy complications.
Main Methods:
- Re-analysis of existing studies, such as the VISP trial, excluding confounding variables.
- Examination of data from large-scale trials and population-based observations, including the HOPE 2 trial and effects of grain fortification.
Main Results:
- Re-analysis of the VISP study indicated a 21% reduction in stroke risk after adjustments.
- The HOPE 2 trial and folate fortification in grain products demonstrated significant reductions in stroke mortality (8-16%).
- Evidence suggests B-vitamin supplementation can lower stroke risk by approximately 20%, reduce osteoporotic fracture risk, and decrease pregnancy complications.
Conclusions:
- B-vitamin supplementation, particularly with folate, is effective in reducing stroke risk and mortality.
- Addressing Hyperhomocysteinemia through vitamin supplementation offers potential benefits for reducing osteoporotic fractures, mitigating cognitive decline, and preventing pregnancy complications.
Abstract:
Hyperhomocysteinemia (HHCY) is a risk factor for cardiovascular (CVD) and neurodegenerative diseases, osteoporotic fractures and pregnancy complications. HHCY is common and is mostly related to B-vitamin deficiency. Retrospective and prospective studies emphasise the causal relationship between HHCY and CVD risk. Some reported vitamin intervention trials, however, did not demonstrate lower risk of CVD after treatment. Confounding factors on the one hand and low subject numbers on the other hand reduced the statistical power of the results. Re-analysis of the VISP study (after excluding renal failure and vitamin B12 status tampering factors), detected a 21% decrease in the risk of stroke. This number has been confirmed by results from the HOPE 2 vitamin intervention trial. A significant decline of stroke-mortality (8 to 16%) has been observed in the USA and Canada after fortification of grain products with folate. Despite negative results from secondary prevention trials regarding the CVD risk reduction there is convincing evidence about the effectiveness of B-vitamin supplementation in lowering the risk of stroke (approximately 20%). Additionally, HHCY was recently linked to the occurrence and severity of chronic heart insufficiency. HHCY is also a risk factor for osteoporotic fractures and vitamin treatment can lower the fracture risk. HHCY predicts the decline in cognitive function with age. Hypomethylation is among the central mechanisms through which HHCY may damage the brain. HHCY and low folate are causal factors for pregnancy complications. In addition to the recommended folate supplementation, vitamin B12 supplementation may also decrease pregnancy complications.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Jaundice
Amebiasis

